Table 2.
Symptom | Estimate | s.e. | t | p | p adjusted | R2 | adj. R2 |
---|---|---|---|---|---|---|---|
A. Cognitive effort cost, MDD | |||||||
Overall depression | −0.37 | 0.16 | −2.24 | 0.030* | 0.120 | 0.045 | |
Anhedonia | −0.17 | 0.15 | −1.18 | 0.245 | 0.286 | ||
Anxiety | −0.50 | 0.13 | −3.70 | 0.001 | 0.004* | 0.246 | 0.182 |
Behavioral apathy | −0.19 | 0.15 | −1.28 | 0.205 | 0.286 | ||
Social apathy | 0.01 | 0.15 | 0.06 | 0.950 | 0.950 | ||
Cognitive function symptoms | −0.30 | 0.14 | −2.08 | 0.043 | 0.150 | ||
Depressed mood/suicidality | −0.26 | 0.17 | −1.56 | 0.126 | 0.253 | ||
Physical anergia/slowing | −0.22 | 0.15 | −1.48 | 0.145 | 0.253 | ||
B. Physical effort cost, MDD | |||||||
Overall depression | 0.04 | 0.17 | 0.21 | 0.833 | |||
Anhedonia | 0.42 | 0.14 | 2.93 | 0.005 | 0.035* | 0.193 | 0.103 |
Anxiety | −0.04 | 0.15 | −0.26 | 0.793 | 0.793 | ||
Behavioral apathy | 0.39 | 0.15 | 2.71 | 0.010 | 0.035* | 0.173 | 0.082 |
Social apathy | 0.14 | 0.15 | 0.93 | 0.355 | 0.492 | ||
Cognitive function symptoms | 0.27 | 0.16 | 1.67 | 0.103 | 0.240 | ||
Depressed mood/suicidality | 0.13 | 0.17 | 0.81 | 0.422 | 0.492 | ||
Physical anergia/slowing | 0.16 | 0.16 | 1.00 | 0.324 | 0.492 | ||
C. Cognitive effort cost, MDD, controlling for anxiety | |||||||
Anhedonia | −0.06 | 0.14 | −0.40 | ||||
Behavioral apathy | −0.06 | 0.14 | −0.40 | 0.689 | 0.991 | ||
Social apathy | 0.01 | 0.13 | 0.07 | 0.947 | 0.991 | ||
Cognitive function symptoms | 0.001 | 0.17 | 0.01 | 0.991 | 0.991 | ||
Depressed mood/suicidality | 0.13 | 0.19 | 0.67 | 0.508 | 0.991 | ||
Physical anergia/slowing | 0.06 | 0.16 | 0.39 | 0.696 | 0.991 |
(A) Predicting cognitive effort cost from overall depression severity, and each symptom domain, controlling for cognitive task performance (3-Back D’) years of education and age. (B) Predicting physical effort cost from overall depression severity, and each symptom domain, controlling for physical task performance (% larger number of presses completed), BMI, years of education and age. (C) Predicting cognitive effort cost from each symptom domain, controlling for anxiety, cognitive task performance (3-Back D’) and age (* indicates p < 0.05, FDR correction within symptom models). R2 and adjusted R2 displayed for significant models. All variables were scaled as input to the regressions.